Market Overview

Oppenheimer Reiterates Outperform on Alimera Sciences, Inc., Lowers PT to $3.00

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ALIM

DateFirmActionFromTo
Nov 2014Summer StreetInitiates Coverage onBuy
Oct 2013Cowen & CompanyUpgradesMarket PerformOutperform
Oct 2013Northland SecuritiesUpgradesOutperform

View More Analyst Ratings for ALIM
View the Latest Analyst Ratings

Posted-In: News Reiteration Analyst Ratings

 

Related Articles (ALIM)

Around the Web, We're Loving...

Get Benzinga's Newsletters